MRE11 and neoplasm: As tumour cells overexpressing MRE11 exhibit a poor response to radiotherapy and chemotherapy and MRE11 deficiency leads to inhibition of DSB repair and enhances radio- and chemosensitivity in tumour cells [12, 14, 30–32], MRE11 is a potential target for increasing radio- and chemosensitivity.